Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights
Many compounds containing the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, including cinnamamide derivatives, have been shown to inhibit tyrosinase potently in vitro and in vivo. Structural changes to cinnamamide derivatives were produced by adding a dithionate functional group to provide eigh...
Ausführliche Beschreibung
Autor*in: |
Jeongin Ko [verfasserIn] Jieun Lee [verfasserIn] Hee Jin Jung [verfasserIn] Sultan Ullah [verfasserIn] Yeongmu Jeong [verfasserIn] Sojeong Hong [verfasserIn] Min Kyung Kang [verfasserIn] Yu Jung Park [verfasserIn] YeJi Hwang [verfasserIn] Dongwan Kang [verfasserIn] Yujin Park [verfasserIn] Pusoon Chun [verfasserIn] Jin-Wook Yoo [verfasserIn] Hae Young Chung [verfasserIn] Hyung Ryong Moon [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2022 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Antioxidants - MDPI AG, 2013, 11(2022), 10, p 1918 |
---|---|
Übergeordnetes Werk: |
volume:11 ; year:2022 ; number:10, p 1918 |
Links: |
---|
DOI / URN: |
10.3390/antiox11101918 |
---|
Katalog-ID: |
DOAJ028007697 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ028007697 | ||
003 | DE-627 | ||
005 | 20240414182029.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/antiox11101918 |2 doi | |
035 | |a (DE-627)DOAJ028007697 | ||
035 | |a (DE-599)DOAJ5137a8168c4242748a642c8b1280a248 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RM1-950 | |
100 | 0 | |a Jeongin Ko |e verfasserin |4 aut | |
245 | 1 | 0 | |a Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Many compounds containing the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, including cinnamamide derivatives, have been shown to inhibit tyrosinase potently in vitro and in vivo. Structural changes to cinnamamide derivatives were produced by adding a dithionate functional group to provide eight (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs with high log <i<p</i< values for skin. These analogs were synthesized using a two-step reaction, and their stereochemistry was confirmed using the <sup<3</sup<<i<J</i<<sub<C4-Hβ</sub< values of C4 measured in proton-coupled <sup<13</sup<C mode. Analogs <b<2</b< (IC<sub<50</sub< = 5.21 ± 0.86 µM) and <b<3</b< (IC<sub<50</sub< = 1.03 ± 0.14 µM) more potently inhibited mushroom tyrosinase than kojic acid (IC<sub<50</sub< = 25.26 ± 1.10 µM). Docking results showed <b<2</b< binds strongly to the active site of tyrosinase, while <b<3</b< binds strongly to an allosteric site. Kinetic studies using <span style="font-variant: small-caps;"<l</span<-tyrosine as substrate indicated <b<2</b< and <b<3</b< competitively and non-competitively inhibit tyrosinase, respectively, which was supported by our docking results. In B16F10 cells, <b<3</b< significantly and concentration-dependently reduced α–MSH plus IBMX induced increases in cellular tyrosinase activity and melanin production and the similarity between these inhibitory patterns implied that the anti-melanogenic effect of <b<3</b< might be due to its tyrosinase-inhibitory ability. In addition, <b<2</b< and <b<3</b< exhibited strong antioxidant effects; for example, they reduced ROS and ONOO<sup<–</sup< levels and exhibited radical scavenging activities, suggesting that these effects might underlie their anti-melanogenic effects. Furthermore, <b<3</b< suppressed the expressions of melanogenesis-associated proteins and genes in B16F10 cells. These results suggest (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs offer a means of producing novel anti-melanogenesis agents. | ||
650 | 4 | |a tyrosinase | |
650 | 4 | |a PUSC scaffold | |
650 | 4 | |a antioxidant | |
650 | 4 | |a anti-melanogenesis | |
650 | 4 | |a docking | |
650 | 4 | |a rhodanine | |
653 | 0 | |a Therapeutics. Pharmacology | |
700 | 0 | |a Jieun Lee |e verfasserin |4 aut | |
700 | 0 | |a Hee Jin Jung |e verfasserin |4 aut | |
700 | 0 | |a Sultan Ullah |e verfasserin |4 aut | |
700 | 0 | |a Yeongmu Jeong |e verfasserin |4 aut | |
700 | 0 | |a Sojeong Hong |e verfasserin |4 aut | |
700 | 0 | |a Min Kyung Kang |e verfasserin |4 aut | |
700 | 0 | |a Yu Jung Park |e verfasserin |4 aut | |
700 | 0 | |a YeJi Hwang |e verfasserin |4 aut | |
700 | 0 | |a Dongwan Kang |e verfasserin |4 aut | |
700 | 0 | |a Yujin Park |e verfasserin |4 aut | |
700 | 0 | |a Pusoon Chun |e verfasserin |4 aut | |
700 | 0 | |a Jin-Wook Yoo |e verfasserin |4 aut | |
700 | 0 | |a Hae Young Chung |e verfasserin |4 aut | |
700 | 0 | |a Hyung Ryong Moon |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Antioxidants |d MDPI AG, 2013 |g 11(2022), 10, p 1918 |w (DE-627)737287578 |w (DE-600)2704216-9 |x 20763921 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2022 |g number:10, p 1918 |
856 | 4 | 0 | |u https://doi.org/10.3390/antiox11101918 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/5137a8168c4242748a642c8b1280a248 |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/2076-3921/11/10/1918 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2076-3921 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 11 |j 2022 |e 10, p 1918 |
author_variant |
j k jk j l jl h j j hjj s u su y j yj s h sh m k k mkk y j p yjp y h yh d k dk y p yp p c pc j w y jwy h y c hyc h r m hrm |
---|---|
matchkey_str |
article:20763921:2022----::einnsnhssfz5usiuebnyieeccoey2hoohaoii4naaoussniyoiaenatoi |
hierarchy_sort_str |
2022 |
callnumber-subject-code |
RM |
publishDate |
2022 |
allfields |
10.3390/antiox11101918 doi (DE-627)DOAJ028007697 (DE-599)DOAJ5137a8168c4242748a642c8b1280a248 DE-627 ger DE-627 rakwb eng RM1-950 Jeongin Ko verfasserin aut Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Many compounds containing the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, including cinnamamide derivatives, have been shown to inhibit tyrosinase potently in vitro and in vivo. Structural changes to cinnamamide derivatives were produced by adding a dithionate functional group to provide eight (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs with high log <i<p</i< values for skin. These analogs were synthesized using a two-step reaction, and their stereochemistry was confirmed using the <sup<3</sup<<i<J</i<<sub<C4-Hβ</sub< values of C4 measured in proton-coupled <sup<13</sup<C mode. Analogs <b<2</b< (IC<sub<50</sub< = 5.21 ± 0.86 µM) and <b<3</b< (IC<sub<50</sub< = 1.03 ± 0.14 µM) more potently inhibited mushroom tyrosinase than kojic acid (IC<sub<50</sub< = 25.26 ± 1.10 µM). Docking results showed <b<2</b< binds strongly to the active site of tyrosinase, while <b<3</b< binds strongly to an allosteric site. Kinetic studies using <span style="font-variant: small-caps;"<l</span<-tyrosine as substrate indicated <b<2</b< and <b<3</b< competitively and non-competitively inhibit tyrosinase, respectively, which was supported by our docking results. In B16F10 cells, <b<3</b< significantly and concentration-dependently reduced α–MSH plus IBMX induced increases in cellular tyrosinase activity and melanin production and the similarity between these inhibitory patterns implied that the anti-melanogenic effect of <b<3</b< might be due to its tyrosinase-inhibitory ability. In addition, <b<2</b< and <b<3</b< exhibited strong antioxidant effects; for example, they reduced ROS and ONOO<sup<–</sup< levels and exhibited radical scavenging activities, suggesting that these effects might underlie their anti-melanogenic effects. Furthermore, <b<3</b< suppressed the expressions of melanogenesis-associated proteins and genes in B16F10 cells. These results suggest (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs offer a means of producing novel anti-melanogenesis agents. tyrosinase PUSC scaffold antioxidant anti-melanogenesis docking rhodanine Therapeutics. Pharmacology Jieun Lee verfasserin aut Hee Jin Jung verfasserin aut Sultan Ullah verfasserin aut Yeongmu Jeong verfasserin aut Sojeong Hong verfasserin aut Min Kyung Kang verfasserin aut Yu Jung Park verfasserin aut YeJi Hwang verfasserin aut Dongwan Kang verfasserin aut Yujin Park verfasserin aut Pusoon Chun verfasserin aut Jin-Wook Yoo verfasserin aut Hae Young Chung verfasserin aut Hyung Ryong Moon verfasserin aut In Antioxidants MDPI AG, 2013 11(2022), 10, p 1918 (DE-627)737287578 (DE-600)2704216-9 20763921 nnns volume:11 year:2022 number:10, p 1918 https://doi.org/10.3390/antiox11101918 kostenfrei https://doaj.org/article/5137a8168c4242748a642c8b1280a248 kostenfrei https://www.mdpi.com/2076-3921/11/10/1918 kostenfrei https://doaj.org/toc/2076-3921 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2022 10, p 1918 |
spelling |
10.3390/antiox11101918 doi (DE-627)DOAJ028007697 (DE-599)DOAJ5137a8168c4242748a642c8b1280a248 DE-627 ger DE-627 rakwb eng RM1-950 Jeongin Ko verfasserin aut Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Many compounds containing the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, including cinnamamide derivatives, have been shown to inhibit tyrosinase potently in vitro and in vivo. Structural changes to cinnamamide derivatives were produced by adding a dithionate functional group to provide eight (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs with high log <i<p</i< values for skin. These analogs were synthesized using a two-step reaction, and their stereochemistry was confirmed using the <sup<3</sup<<i<J</i<<sub<C4-Hβ</sub< values of C4 measured in proton-coupled <sup<13</sup<C mode. Analogs <b<2</b< (IC<sub<50</sub< = 5.21 ± 0.86 µM) and <b<3</b< (IC<sub<50</sub< = 1.03 ± 0.14 µM) more potently inhibited mushroom tyrosinase than kojic acid (IC<sub<50</sub< = 25.26 ± 1.10 µM). Docking results showed <b<2</b< binds strongly to the active site of tyrosinase, while <b<3</b< binds strongly to an allosteric site. Kinetic studies using <span style="font-variant: small-caps;"<l</span<-tyrosine as substrate indicated <b<2</b< and <b<3</b< competitively and non-competitively inhibit tyrosinase, respectively, which was supported by our docking results. In B16F10 cells, <b<3</b< significantly and concentration-dependently reduced α–MSH plus IBMX induced increases in cellular tyrosinase activity and melanin production and the similarity between these inhibitory patterns implied that the anti-melanogenic effect of <b<3</b< might be due to its tyrosinase-inhibitory ability. In addition, <b<2</b< and <b<3</b< exhibited strong antioxidant effects; for example, they reduced ROS and ONOO<sup<–</sup< levels and exhibited radical scavenging activities, suggesting that these effects might underlie their anti-melanogenic effects. Furthermore, <b<3</b< suppressed the expressions of melanogenesis-associated proteins and genes in B16F10 cells. These results suggest (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs offer a means of producing novel anti-melanogenesis agents. tyrosinase PUSC scaffold antioxidant anti-melanogenesis docking rhodanine Therapeutics. Pharmacology Jieun Lee verfasserin aut Hee Jin Jung verfasserin aut Sultan Ullah verfasserin aut Yeongmu Jeong verfasserin aut Sojeong Hong verfasserin aut Min Kyung Kang verfasserin aut Yu Jung Park verfasserin aut YeJi Hwang verfasserin aut Dongwan Kang verfasserin aut Yujin Park verfasserin aut Pusoon Chun verfasserin aut Jin-Wook Yoo verfasserin aut Hae Young Chung verfasserin aut Hyung Ryong Moon verfasserin aut In Antioxidants MDPI AG, 2013 11(2022), 10, p 1918 (DE-627)737287578 (DE-600)2704216-9 20763921 nnns volume:11 year:2022 number:10, p 1918 https://doi.org/10.3390/antiox11101918 kostenfrei https://doaj.org/article/5137a8168c4242748a642c8b1280a248 kostenfrei https://www.mdpi.com/2076-3921/11/10/1918 kostenfrei https://doaj.org/toc/2076-3921 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2022 10, p 1918 |
allfields_unstemmed |
10.3390/antiox11101918 doi (DE-627)DOAJ028007697 (DE-599)DOAJ5137a8168c4242748a642c8b1280a248 DE-627 ger DE-627 rakwb eng RM1-950 Jeongin Ko verfasserin aut Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Many compounds containing the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, including cinnamamide derivatives, have been shown to inhibit tyrosinase potently in vitro and in vivo. Structural changes to cinnamamide derivatives were produced by adding a dithionate functional group to provide eight (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs with high log <i<p</i< values for skin. These analogs were synthesized using a two-step reaction, and their stereochemistry was confirmed using the <sup<3</sup<<i<J</i<<sub<C4-Hβ</sub< values of C4 measured in proton-coupled <sup<13</sup<C mode. Analogs <b<2</b< (IC<sub<50</sub< = 5.21 ± 0.86 µM) and <b<3</b< (IC<sub<50</sub< = 1.03 ± 0.14 µM) more potently inhibited mushroom tyrosinase than kojic acid (IC<sub<50</sub< = 25.26 ± 1.10 µM). Docking results showed <b<2</b< binds strongly to the active site of tyrosinase, while <b<3</b< binds strongly to an allosteric site. Kinetic studies using <span style="font-variant: small-caps;"<l</span<-tyrosine as substrate indicated <b<2</b< and <b<3</b< competitively and non-competitively inhibit tyrosinase, respectively, which was supported by our docking results. In B16F10 cells, <b<3</b< significantly and concentration-dependently reduced α–MSH plus IBMX induced increases in cellular tyrosinase activity and melanin production and the similarity between these inhibitory patterns implied that the anti-melanogenic effect of <b<3</b< might be due to its tyrosinase-inhibitory ability. In addition, <b<2</b< and <b<3</b< exhibited strong antioxidant effects; for example, they reduced ROS and ONOO<sup<–</sup< levels and exhibited radical scavenging activities, suggesting that these effects might underlie their anti-melanogenic effects. Furthermore, <b<3</b< suppressed the expressions of melanogenesis-associated proteins and genes in B16F10 cells. These results suggest (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs offer a means of producing novel anti-melanogenesis agents. tyrosinase PUSC scaffold antioxidant anti-melanogenesis docking rhodanine Therapeutics. Pharmacology Jieun Lee verfasserin aut Hee Jin Jung verfasserin aut Sultan Ullah verfasserin aut Yeongmu Jeong verfasserin aut Sojeong Hong verfasserin aut Min Kyung Kang verfasserin aut Yu Jung Park verfasserin aut YeJi Hwang verfasserin aut Dongwan Kang verfasserin aut Yujin Park verfasserin aut Pusoon Chun verfasserin aut Jin-Wook Yoo verfasserin aut Hae Young Chung verfasserin aut Hyung Ryong Moon verfasserin aut In Antioxidants MDPI AG, 2013 11(2022), 10, p 1918 (DE-627)737287578 (DE-600)2704216-9 20763921 nnns volume:11 year:2022 number:10, p 1918 https://doi.org/10.3390/antiox11101918 kostenfrei https://doaj.org/article/5137a8168c4242748a642c8b1280a248 kostenfrei https://www.mdpi.com/2076-3921/11/10/1918 kostenfrei https://doaj.org/toc/2076-3921 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2022 10, p 1918 |
allfieldsGer |
10.3390/antiox11101918 doi (DE-627)DOAJ028007697 (DE-599)DOAJ5137a8168c4242748a642c8b1280a248 DE-627 ger DE-627 rakwb eng RM1-950 Jeongin Ko verfasserin aut Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Many compounds containing the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, including cinnamamide derivatives, have been shown to inhibit tyrosinase potently in vitro and in vivo. Structural changes to cinnamamide derivatives were produced by adding a dithionate functional group to provide eight (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs with high log <i<p</i< values for skin. These analogs were synthesized using a two-step reaction, and their stereochemistry was confirmed using the <sup<3</sup<<i<J</i<<sub<C4-Hβ</sub< values of C4 measured in proton-coupled <sup<13</sup<C mode. Analogs <b<2</b< (IC<sub<50</sub< = 5.21 ± 0.86 µM) and <b<3</b< (IC<sub<50</sub< = 1.03 ± 0.14 µM) more potently inhibited mushroom tyrosinase than kojic acid (IC<sub<50</sub< = 25.26 ± 1.10 µM). Docking results showed <b<2</b< binds strongly to the active site of tyrosinase, while <b<3</b< binds strongly to an allosteric site. Kinetic studies using <span style="font-variant: small-caps;"<l</span<-tyrosine as substrate indicated <b<2</b< and <b<3</b< competitively and non-competitively inhibit tyrosinase, respectively, which was supported by our docking results. In B16F10 cells, <b<3</b< significantly and concentration-dependently reduced α–MSH plus IBMX induced increases in cellular tyrosinase activity and melanin production and the similarity between these inhibitory patterns implied that the anti-melanogenic effect of <b<3</b< might be due to its tyrosinase-inhibitory ability. In addition, <b<2</b< and <b<3</b< exhibited strong antioxidant effects; for example, they reduced ROS and ONOO<sup<–</sup< levels and exhibited radical scavenging activities, suggesting that these effects might underlie their anti-melanogenic effects. Furthermore, <b<3</b< suppressed the expressions of melanogenesis-associated proteins and genes in B16F10 cells. These results suggest (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs offer a means of producing novel anti-melanogenesis agents. tyrosinase PUSC scaffold antioxidant anti-melanogenesis docking rhodanine Therapeutics. Pharmacology Jieun Lee verfasserin aut Hee Jin Jung verfasserin aut Sultan Ullah verfasserin aut Yeongmu Jeong verfasserin aut Sojeong Hong verfasserin aut Min Kyung Kang verfasserin aut Yu Jung Park verfasserin aut YeJi Hwang verfasserin aut Dongwan Kang verfasserin aut Yujin Park verfasserin aut Pusoon Chun verfasserin aut Jin-Wook Yoo verfasserin aut Hae Young Chung verfasserin aut Hyung Ryong Moon verfasserin aut In Antioxidants MDPI AG, 2013 11(2022), 10, p 1918 (DE-627)737287578 (DE-600)2704216-9 20763921 nnns volume:11 year:2022 number:10, p 1918 https://doi.org/10.3390/antiox11101918 kostenfrei https://doaj.org/article/5137a8168c4242748a642c8b1280a248 kostenfrei https://www.mdpi.com/2076-3921/11/10/1918 kostenfrei https://doaj.org/toc/2076-3921 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2022 10, p 1918 |
allfieldsSound |
10.3390/antiox11101918 doi (DE-627)DOAJ028007697 (DE-599)DOAJ5137a8168c4242748a642c8b1280a248 DE-627 ger DE-627 rakwb eng RM1-950 Jeongin Ko verfasserin aut Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Many compounds containing the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, including cinnamamide derivatives, have been shown to inhibit tyrosinase potently in vitro and in vivo. Structural changes to cinnamamide derivatives were produced by adding a dithionate functional group to provide eight (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs with high log <i<p</i< values for skin. These analogs were synthesized using a two-step reaction, and their stereochemistry was confirmed using the <sup<3</sup<<i<J</i<<sub<C4-Hβ</sub< values of C4 measured in proton-coupled <sup<13</sup<C mode. Analogs <b<2</b< (IC<sub<50</sub< = 5.21 ± 0.86 µM) and <b<3</b< (IC<sub<50</sub< = 1.03 ± 0.14 µM) more potently inhibited mushroom tyrosinase than kojic acid (IC<sub<50</sub< = 25.26 ± 1.10 µM). Docking results showed <b<2</b< binds strongly to the active site of tyrosinase, while <b<3</b< binds strongly to an allosteric site. Kinetic studies using <span style="font-variant: small-caps;"<l</span<-tyrosine as substrate indicated <b<2</b< and <b<3</b< competitively and non-competitively inhibit tyrosinase, respectively, which was supported by our docking results. In B16F10 cells, <b<3</b< significantly and concentration-dependently reduced α–MSH plus IBMX induced increases in cellular tyrosinase activity and melanin production and the similarity between these inhibitory patterns implied that the anti-melanogenic effect of <b<3</b< might be due to its tyrosinase-inhibitory ability. In addition, <b<2</b< and <b<3</b< exhibited strong antioxidant effects; for example, they reduced ROS and ONOO<sup<–</sup< levels and exhibited radical scavenging activities, suggesting that these effects might underlie their anti-melanogenic effects. Furthermore, <b<3</b< suppressed the expressions of melanogenesis-associated proteins and genes in B16F10 cells. These results suggest (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs offer a means of producing novel anti-melanogenesis agents. tyrosinase PUSC scaffold antioxidant anti-melanogenesis docking rhodanine Therapeutics. Pharmacology Jieun Lee verfasserin aut Hee Jin Jung verfasserin aut Sultan Ullah verfasserin aut Yeongmu Jeong verfasserin aut Sojeong Hong verfasserin aut Min Kyung Kang verfasserin aut Yu Jung Park verfasserin aut YeJi Hwang verfasserin aut Dongwan Kang verfasserin aut Yujin Park verfasserin aut Pusoon Chun verfasserin aut Jin-Wook Yoo verfasserin aut Hae Young Chung verfasserin aut Hyung Ryong Moon verfasserin aut In Antioxidants MDPI AG, 2013 11(2022), 10, p 1918 (DE-627)737287578 (DE-600)2704216-9 20763921 nnns volume:11 year:2022 number:10, p 1918 https://doi.org/10.3390/antiox11101918 kostenfrei https://doaj.org/article/5137a8168c4242748a642c8b1280a248 kostenfrei https://www.mdpi.com/2076-3921/11/10/1918 kostenfrei https://doaj.org/toc/2076-3921 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2022 10, p 1918 |
language |
English |
source |
In Antioxidants 11(2022), 10, p 1918 volume:11 year:2022 number:10, p 1918 |
sourceStr |
In Antioxidants 11(2022), 10, p 1918 volume:11 year:2022 number:10, p 1918 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
tyrosinase PUSC scaffold antioxidant anti-melanogenesis docking rhodanine Therapeutics. Pharmacology |
isfreeaccess_bool |
true |
container_title |
Antioxidants |
authorswithroles_txt_mv |
Jeongin Ko @@aut@@ Jieun Lee @@aut@@ Hee Jin Jung @@aut@@ Sultan Ullah @@aut@@ Yeongmu Jeong @@aut@@ Sojeong Hong @@aut@@ Min Kyung Kang @@aut@@ Yu Jung Park @@aut@@ YeJi Hwang @@aut@@ Dongwan Kang @@aut@@ Yujin Park @@aut@@ Pusoon Chun @@aut@@ Jin-Wook Yoo @@aut@@ Hae Young Chung @@aut@@ Hyung Ryong Moon @@aut@@ |
publishDateDaySort_date |
2022-01-01T00:00:00Z |
hierarchy_top_id |
737287578 |
id |
DOAJ028007697 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ028007697</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414182029.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/antiox11101918</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ028007697</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ5137a8168c4242748a642c8b1280a248</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Jeongin Ko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Many compounds containing the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, including cinnamamide derivatives, have been shown to inhibit tyrosinase potently in vitro and in vivo. Structural changes to cinnamamide derivatives were produced by adding a dithionate functional group to provide eight (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs with high log <i<p</i< values for skin. These analogs were synthesized using a two-step reaction, and their stereochemistry was confirmed using the <sup<3</sup<<i<J</i<<sub<C4-Hβ</sub< values of C4 measured in proton-coupled <sup<13</sup<C mode. Analogs <b<2</b< (IC<sub<50</sub< = 5.21 ± 0.86 µM) and <b<3</b< (IC<sub<50</sub< = 1.03 ± 0.14 µM) more potently inhibited mushroom tyrosinase than kojic acid (IC<sub<50</sub< = 25.26 ± 1.10 µM). Docking results showed <b<2</b< binds strongly to the active site of tyrosinase, while <b<3</b< binds strongly to an allosteric site. Kinetic studies using <span style="font-variant: small-caps;"<l</span<-tyrosine as substrate indicated <b<2</b< and <b<3</b< competitively and non-competitively inhibit tyrosinase, respectively, which was supported by our docking results. In B16F10 cells, <b<3</b< significantly and concentration-dependently reduced α–MSH plus IBMX induced increases in cellular tyrosinase activity and melanin production and the similarity between these inhibitory patterns implied that the anti-melanogenic effect of <b<3</b< might be due to its tyrosinase-inhibitory ability. In addition, <b<2</b< and <b<3</b< exhibited strong antioxidant effects; for example, they reduced ROS and ONOO<sup<–</sup< levels and exhibited radical scavenging activities, suggesting that these effects might underlie their anti-melanogenic effects. Furthermore, <b<3</b< suppressed the expressions of melanogenesis-associated proteins and genes in B16F10 cells. These results suggest (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs offer a means of producing novel anti-melanogenesis agents.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">tyrosinase</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">PUSC scaffold</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">antioxidant</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">anti-melanogenesis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">docking</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">rhodanine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jieun Lee</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hee Jin Jung</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sultan Ullah</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yeongmu Jeong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sojeong Hong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Min Kyung Kang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yu Jung Park</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">YeJi Hwang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Dongwan Kang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yujin Park</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Pusoon Chun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jin-Wook Yoo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hae Young Chung</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hyung Ryong Moon</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Antioxidants</subfield><subfield code="d">MDPI AG, 2013</subfield><subfield code="g">11(2022), 10, p 1918</subfield><subfield code="w">(DE-627)737287578</subfield><subfield code="w">(DE-600)2704216-9</subfield><subfield code="x">20763921</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:10, p 1918</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/antiox11101918</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/5137a8168c4242748a642c8b1280a248</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2076-3921/11/10/1918</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2076-3921</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2022</subfield><subfield code="e">10, p 1918</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Jeongin Ko |
spellingShingle |
Jeongin Ko misc RM1-950 misc tyrosinase misc PUSC scaffold misc antioxidant misc anti-melanogenesis misc docking misc rhodanine misc Therapeutics. Pharmacology Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights |
authorStr |
Jeongin Ko |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)737287578 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RM1-950 |
illustrated |
Not Illustrated |
issn |
20763921 |
topic_title |
RM1-950 Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights tyrosinase PUSC scaffold antioxidant anti-melanogenesis docking rhodanine |
topic |
misc RM1-950 misc tyrosinase misc PUSC scaffold misc antioxidant misc anti-melanogenesis misc docking misc rhodanine misc Therapeutics. Pharmacology |
topic_unstemmed |
misc RM1-950 misc tyrosinase misc PUSC scaffold misc antioxidant misc anti-melanogenesis misc docking misc rhodanine misc Therapeutics. Pharmacology |
topic_browse |
misc RM1-950 misc tyrosinase misc PUSC scaffold misc antioxidant misc anti-melanogenesis misc docking misc rhodanine misc Therapeutics. Pharmacology |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Antioxidants |
hierarchy_parent_id |
737287578 |
hierarchy_top_title |
Antioxidants |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)737287578 (DE-600)2704216-9 |
title |
Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights |
ctrlnum |
(DE-627)DOAJ028007697 (DE-599)DOAJ5137a8168c4242748a642c8b1280a248 |
title_full |
Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights |
author_sort |
Jeongin Ko |
journal |
Antioxidants |
journalStr |
Antioxidants |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2022 |
contenttype_str_mv |
txt |
author_browse |
Jeongin Ko Jieun Lee Hee Jin Jung Sultan Ullah Yeongmu Jeong Sojeong Hong Min Kyung Kang Yu Jung Park YeJi Hwang Dongwan Kang Yujin Park Pusoon Chun Jin-Wook Yoo Hae Young Chung Hyung Ryong Moon |
container_volume |
11 |
class |
RM1-950 |
format_se |
Elektronische Aufsätze |
author-letter |
Jeongin Ko |
doi_str_mv |
10.3390/antiox11101918 |
author2-role |
verfasserin |
title_sort |
design and synthesis of (<i<z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogues as anti-tyrosinase and antioxidant compounds: in vitro and in silico insights |
callnumber |
RM1-950 |
title_auth |
Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights |
abstract |
Many compounds containing the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, including cinnamamide derivatives, have been shown to inhibit tyrosinase potently in vitro and in vivo. Structural changes to cinnamamide derivatives were produced by adding a dithionate functional group to provide eight (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs with high log <i<p</i< values for skin. These analogs were synthesized using a two-step reaction, and their stereochemistry was confirmed using the <sup<3</sup<<i<J</i<<sub<C4-Hβ</sub< values of C4 measured in proton-coupled <sup<13</sup<C mode. Analogs <b<2</b< (IC<sub<50</sub< = 5.21 ± 0.86 µM) and <b<3</b< (IC<sub<50</sub< = 1.03 ± 0.14 µM) more potently inhibited mushroom tyrosinase than kojic acid (IC<sub<50</sub< = 25.26 ± 1.10 µM). Docking results showed <b<2</b< binds strongly to the active site of tyrosinase, while <b<3</b< binds strongly to an allosteric site. Kinetic studies using <span style="font-variant: small-caps;"<l</span<-tyrosine as substrate indicated <b<2</b< and <b<3</b< competitively and non-competitively inhibit tyrosinase, respectively, which was supported by our docking results. In B16F10 cells, <b<3</b< significantly and concentration-dependently reduced α–MSH plus IBMX induced increases in cellular tyrosinase activity and melanin production and the similarity between these inhibitory patterns implied that the anti-melanogenic effect of <b<3</b< might be due to its tyrosinase-inhibitory ability. In addition, <b<2</b< and <b<3</b< exhibited strong antioxidant effects; for example, they reduced ROS and ONOO<sup<–</sup< levels and exhibited radical scavenging activities, suggesting that these effects might underlie their anti-melanogenic effects. Furthermore, <b<3</b< suppressed the expressions of melanogenesis-associated proteins and genes in B16F10 cells. These results suggest (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs offer a means of producing novel anti-melanogenesis agents. |
abstractGer |
Many compounds containing the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, including cinnamamide derivatives, have been shown to inhibit tyrosinase potently in vitro and in vivo. Structural changes to cinnamamide derivatives were produced by adding a dithionate functional group to provide eight (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs with high log <i<p</i< values for skin. These analogs were synthesized using a two-step reaction, and their stereochemistry was confirmed using the <sup<3</sup<<i<J</i<<sub<C4-Hβ</sub< values of C4 measured in proton-coupled <sup<13</sup<C mode. Analogs <b<2</b< (IC<sub<50</sub< = 5.21 ± 0.86 µM) and <b<3</b< (IC<sub<50</sub< = 1.03 ± 0.14 µM) more potently inhibited mushroom tyrosinase than kojic acid (IC<sub<50</sub< = 25.26 ± 1.10 µM). Docking results showed <b<2</b< binds strongly to the active site of tyrosinase, while <b<3</b< binds strongly to an allosteric site. Kinetic studies using <span style="font-variant: small-caps;"<l</span<-tyrosine as substrate indicated <b<2</b< and <b<3</b< competitively and non-competitively inhibit tyrosinase, respectively, which was supported by our docking results. In B16F10 cells, <b<3</b< significantly and concentration-dependently reduced α–MSH plus IBMX induced increases in cellular tyrosinase activity and melanin production and the similarity between these inhibitory patterns implied that the anti-melanogenic effect of <b<3</b< might be due to its tyrosinase-inhibitory ability. In addition, <b<2</b< and <b<3</b< exhibited strong antioxidant effects; for example, they reduced ROS and ONOO<sup<–</sup< levels and exhibited radical scavenging activities, suggesting that these effects might underlie their anti-melanogenic effects. Furthermore, <b<3</b< suppressed the expressions of melanogenesis-associated proteins and genes in B16F10 cells. These results suggest (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs offer a means of producing novel anti-melanogenesis agents. |
abstract_unstemmed |
Many compounds containing the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, including cinnamamide derivatives, have been shown to inhibit tyrosinase potently in vitro and in vivo. Structural changes to cinnamamide derivatives were produced by adding a dithionate functional group to provide eight (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs with high log <i<p</i< values for skin. These analogs were synthesized using a two-step reaction, and their stereochemistry was confirmed using the <sup<3</sup<<i<J</i<<sub<C4-Hβ</sub< values of C4 measured in proton-coupled <sup<13</sup<C mode. Analogs <b<2</b< (IC<sub<50</sub< = 5.21 ± 0.86 µM) and <b<3</b< (IC<sub<50</sub< = 1.03 ± 0.14 µM) more potently inhibited mushroom tyrosinase than kojic acid (IC<sub<50</sub< = 25.26 ± 1.10 µM). Docking results showed <b<2</b< binds strongly to the active site of tyrosinase, while <b<3</b< binds strongly to an allosteric site. Kinetic studies using <span style="font-variant: small-caps;"<l</span<-tyrosine as substrate indicated <b<2</b< and <b<3</b< competitively and non-competitively inhibit tyrosinase, respectively, which was supported by our docking results. In B16F10 cells, <b<3</b< significantly and concentration-dependently reduced α–MSH plus IBMX induced increases in cellular tyrosinase activity and melanin production and the similarity between these inhibitory patterns implied that the anti-melanogenic effect of <b<3</b< might be due to its tyrosinase-inhibitory ability. In addition, <b<2</b< and <b<3</b< exhibited strong antioxidant effects; for example, they reduced ROS and ONOO<sup<–</sup< levels and exhibited radical scavenging activities, suggesting that these effects might underlie their anti-melanogenic effects. Furthermore, <b<3</b< suppressed the expressions of melanogenesis-associated proteins and genes in B16F10 cells. These results suggest (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs offer a means of producing novel anti-melanogenesis agents. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
10, p 1918 |
title_short |
Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights |
url |
https://doi.org/10.3390/antiox11101918 https://doaj.org/article/5137a8168c4242748a642c8b1280a248 https://www.mdpi.com/2076-3921/11/10/1918 https://doaj.org/toc/2076-3921 |
remote_bool |
true |
author2 |
Jieun Lee Hee Jin Jung Sultan Ullah Yeongmu Jeong Sojeong Hong Min Kyung Kang Yu Jung Park YeJi Hwang Dongwan Kang Yujin Park Pusoon Chun Jin-Wook Yoo Hae Young Chung Hyung Ryong Moon |
author2Str |
Jieun Lee Hee Jin Jung Sultan Ullah Yeongmu Jeong Sojeong Hong Min Kyung Kang Yu Jung Park YeJi Hwang Dongwan Kang Yujin Park Pusoon Chun Jin-Wook Yoo Hae Young Chung Hyung Ryong Moon |
ppnlink |
737287578 |
callnumber-subject |
RM - Therapeutics and Pharmacology |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.3390/antiox11101918 |
callnumber-a |
RM1-950 |
up_date |
2024-07-03T15:13:27.582Z |
_version_ |
1803571280042000384 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ028007697</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414182029.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/antiox11101918</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ028007697</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ5137a8168c4242748a642c8b1280a248</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Jeongin Ko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Design and Synthesis of (<i<Z</i<)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Many compounds containing the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, including cinnamamide derivatives, have been shown to inhibit tyrosinase potently in vitro and in vivo. Structural changes to cinnamamide derivatives were produced by adding a dithionate functional group to provide eight (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs with high log <i<p</i< values for skin. These analogs were synthesized using a two-step reaction, and their stereochemistry was confirmed using the <sup<3</sup<<i<J</i<<sub<C4-Hβ</sub< values of C4 measured in proton-coupled <sup<13</sup<C mode. Analogs <b<2</b< (IC<sub<50</sub< = 5.21 ± 0.86 µM) and <b<3</b< (IC<sub<50</sub< = 1.03 ± 0.14 µM) more potently inhibited mushroom tyrosinase than kojic acid (IC<sub<50</sub< = 25.26 ± 1.10 µM). Docking results showed <b<2</b< binds strongly to the active site of tyrosinase, while <b<3</b< binds strongly to an allosteric site. Kinetic studies using <span style="font-variant: small-caps;"<l</span<-tyrosine as substrate indicated <b<2</b< and <b<3</b< competitively and non-competitively inhibit tyrosinase, respectively, which was supported by our docking results. In B16F10 cells, <b<3</b< significantly and concentration-dependently reduced α–MSH plus IBMX induced increases in cellular tyrosinase activity and melanin production and the similarity between these inhibitory patterns implied that the anti-melanogenic effect of <b<3</b< might be due to its tyrosinase-inhibitory ability. In addition, <b<2</b< and <b<3</b< exhibited strong antioxidant effects; for example, they reduced ROS and ONOO<sup<–</sup< levels and exhibited radical scavenging activities, suggesting that these effects might underlie their anti-melanogenic effects. Furthermore, <b<3</b< suppressed the expressions of melanogenesis-associated proteins and genes in B16F10 cells. These results suggest (<i<Z</i<)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs offer a means of producing novel anti-melanogenesis agents.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">tyrosinase</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">PUSC scaffold</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">antioxidant</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">anti-melanogenesis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">docking</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">rhodanine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jieun Lee</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hee Jin Jung</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sultan Ullah</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yeongmu Jeong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sojeong Hong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Min Kyung Kang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yu Jung Park</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">YeJi Hwang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Dongwan Kang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yujin Park</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Pusoon Chun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jin-Wook Yoo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hae Young Chung</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hyung Ryong Moon</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Antioxidants</subfield><subfield code="d">MDPI AG, 2013</subfield><subfield code="g">11(2022), 10, p 1918</subfield><subfield code="w">(DE-627)737287578</subfield><subfield code="w">(DE-600)2704216-9</subfield><subfield code="x">20763921</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:10, p 1918</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/antiox11101918</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/5137a8168c4242748a642c8b1280a248</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2076-3921/11/10/1918</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2076-3921</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2022</subfield><subfield code="e">10, p 1918</subfield></datafield></record></collection>
|
score |
7.4002304 |